Atlas Trials

Samarium Sm 153 Lexidronam Pentasodium and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma

Clinical trial NCT00478075 · COMPLETED

Trial details

NCT number
NCT00478075
Sponsor
Mayo Clinic
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Multiple Myeloma and Plasma Cell Neoplasm
Start date
2005-09-01
Primary completion
2007-11-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.